Fetal Endocrine Disruption by Triclosan

三氯生干扰胎儿内分泌

基本信息

  • 批准号:
    8175088
  • 负责人:
  • 金额:
    $ 21.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-09 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Estrogen is, in a sense, an organizing principle for the fetus, promoting readiness for birth and neonatal survival. The placenta provides nearly all of the estrogen that circulates in fetal blood, through secretion in the form of sulfate conjugates of estradiol and related estrogens. These sulfate conjugates are formed in the placenta by the enzyme estrogen sulfotransferase (SULT1E1), which is highly expressed in the placenta. The secreted estrogen sulfate conjugates are converted to free estradiol and related estrogens in target tissues through the action of another enzyme, sulfatase. Triclosan, an antibacterial agent to which people are exposed through use of soaps, toothpaste and other personal care products containing Triclosan, is a very potent inhibitor of SULT1E1. Although many agree that inhibiting SULT1E1 is likely to disrupt estrogen biosynthesis or metabolism, to date, no one has examined the in vivo significance of SULT1E1 inhibition in the fetus. This proposal will use the fetal sheep model of in utero fetal development to examine the consequences of inhibiting placental SULT1E1. One specific aim is proposed. We will test the hypothesis that exposure of fetal sheep to Triclosan will, because of its inhibition of SULT1E1, reduce circulating estrogen concentrations and have genomic actions that are consistent with decreased estrogen action in the fetus. Methodology will include studies in vivo in chronically-catheterized fetal sheep, molecular analysis of the responses to Triclosan in the experimental animals, and in vitro biochemical assessment of the effect of Triclosan on plasma and tissue analyte concentrations. This project is the first in vivo study of the consequences of inhibiting SULT1E1 in the pregnant animal, using an animal model whose estrogen biosynthesis is far closer to the human being than rodent species. As such, it will provide a mechanistic basis for understanding disturbances in pregnancy outcome and fetal development after exposure to Triclosan and will provide a foundation for future experiments. PUBLIC HEALTH RELEVANCE: This project examines the possibility that exposure to triclosan, an antibacterial agent added to numerous personal care products, reduces the supply of estrogen to the fetus and has adverse effects that are mediated by reduced estrogen action.
描述(由申请人提供):雌激素在某种意义上是胎儿的组织原则,促进出生准备和新生儿存活。胎盘通过分泌雌二醇和相关雌激素的硫酸盐结合物提供几乎所有在胎儿血液中循环的雌激素。这些硫酸盐结合物是由雌激素磺基转移酶(SULT1E1)在胎盘中形成的,该酶在胎盘中高度表达。分泌的雌激素硫酸盐结合物通过另一种酶硫酸酯酶的作用在靶组织中转化为游离雌二醇和相关雌激素。三氯生是一种抗菌剂,人们通过使用含有三氯生的肥皂、牙膏和其他个人护理产品而接触到它,它是SULT 1E1的一种非常有效的抑制剂。尽管许多人认为抑制SULT1E1可能会破坏雌激素的生物合成或代谢,但迄今为止,还没有人研究过SULT1E1抑制在胎儿中的体内意义。该提案将使用子宫内胎儿发育的胎羊模型来检查抑制胎盘SULT 1E1的后果。提出了一个具体目标。我们将检验以下假设:由于三氯生对SULT 1E1的抑制作用,胎羊暴露于三氯生将降低循环雌激素浓度,并具有与胎儿雌激素作用降低一致的基因组作用。方法学将包括长期插管胎羊体内研究、实验动物对三氯生反应的分子分析以及三氯生对血浆和组织分析物浓度影响的体外生化评估。该项目是第一个在怀孕动物中抑制SULT1E1的后果的体内研究,使用的动物模型其雌激素生物合成比啮齿类动物更接近人类。因此,它将为了解接触三氯生后妊娠结局和胎儿发育的紊乱提供机制基础,并为未来的实验提供基础。 公共卫生相关性:该项目研究了暴露于三氯生(一种添加到许多个人护理产品中的抗菌剂)减少对胎儿的雌激素供应并产生由雌激素作用减少介导的不良影响的可能性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margaret Olive James其他文献

Margaret Olive James的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margaret Olive James', 18)}}的其他基金

Diversity Supplement to 2RO1 GM 099871
2RO1 GM 099871 的多样性补充
  • 批准号:
    9405952
  • 财政年份:
    2012
  • 资助金额:
    $ 21.98万
  • 项目类别:
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1
线粒体和胞质 GSTZ1 的发育药理学
  • 批准号:
    9338247
  • 财政年份:
    2012
  • 资助金额:
    $ 21.98万
  • 项目类别:
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI
细胞质和线粒体 GSTZ1-1/MAAI 的发育药理学
  • 批准号:
    8372844
  • 财政年份:
    2012
  • 资助金额:
    $ 21.98万
  • 项目类别:
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI
细胞质和线粒体 GSTZ1-1/MAAI 的发育药理学
  • 批准号:
    8733781
  • 财政年份:
    2012
  • 资助金额:
    $ 21.98万
  • 项目类别:
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI
细胞质和线粒体 GSTZ1-1/MAAI 的发育药理学
  • 批准号:
    8658108
  • 财政年份:
    2012
  • 资助金额:
    $ 21.98万
  • 项目类别:
Developmental Pharmacology of Mitochondrial and Cytosolic GSTZ1
线粒体和胞质 GSTZ1 的发育药理学
  • 批准号:
    9176607
  • 财政年份:
    2012
  • 资助金额:
    $ 21.98万
  • 项目类别:
Developmental Pharmacology of cytosolic and mitochondrial GSTZ1-1/MAAI
细胞质和线粒体 GSTZ1-1/MAAI 的发育药理学
  • 批准号:
    8531995
  • 财政年份:
    2012
  • 资助金额:
    $ 21.98万
  • 项目类别:
Fetal Endocrine Disruption by Triclosan
三氯生干扰胎儿内分泌
  • 批准号:
    8317597
  • 财政年份:
    2011
  • 资助金额:
    $ 21.98万
  • 项目类别:
Modulation of steroid sulfation by celecoxib-like drugs
塞来昔布类药物对类固醇硫酸化的调节
  • 批准号:
    7587000
  • 财政年份:
    2008
  • 资助金额:
    $ 21.98万
  • 项目类别:
Modulation of steroid sulfation by celecoxib-like drugs
塞来昔布类药物对类固醇硫酸化的调节
  • 批准号:
    7686695
  • 财政年份:
    2008
  • 资助金额:
    $ 21.98万
  • 项目类别:

相似海外基金

Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10590611
  • 财政年份:
    2022
  • 资助金额:
    $ 21.98万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
  • 批准号:
    10706006
  • 财政年份:
    2022
  • 资助金额:
    $ 21.98万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10368975
  • 财政年份:
    2021
  • 资助金额:
    $ 21.98万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10365254
  • 财政年份:
    2021
  • 资助金额:
    $ 21.98万
  • 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
  • 批准号:
    10202896
  • 财政年份:
    2021
  • 资助金额:
    $ 21.98万
  • 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
  • 批准号:
    10531570
  • 财政年份:
    2021
  • 资助金额:
    $ 21.98万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10541847
  • 财政年份:
    2019
  • 资助金额:
    $ 21.98万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10319573
  • 财政年份:
    2019
  • 资助金额:
    $ 21.98万
  • 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
  • 批准号:
    10062790
  • 财政年份:
    2019
  • 资助金额:
    $ 21.98万
  • 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
  • 批准号:
    DE170100628
  • 财政年份:
    2017
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Discovery Early Career Researcher Award
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了